- (2022). Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue. Journal of Neuroimmunology.
- (2019). CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration. Annals of Neurology. 316-321.
- (2017). Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies. Cancer Immunology and Immunotherapy. 1463-1471.
- (2016). Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes. Journal of Neurology. 1001-1007.
- (2015). Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies. Journal of the Neurological Sciences. 41-45.
- (2011). Onconeural antibodies in patients with neurological symptoms: detection and clinical significance. Acta Neurologica Scandinavica. 83-88.
Brev til redaktøren
- (2020). Reply to “CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration”. Annals of Neurology. 429.
- (2012). Paraneoplastic neurological manifestations in patients with lung cancer without onconeural antibodies. Journal of Neuroimmunology. 133-133.